Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Plasso Technology was a life sciences company specializing in advanced surface engineering solutions for biotechnology and pharmaceutical research. The company's core technology, Topas, utilized plasma polymerization to create highly controlled surfaces for protein microarrays, cell culture, and diagnostic assays. Their flagship product line, Pro-Link, provided optimized surfaces for the immobilization of proteins while maintaining their biological activity and orientation. Founded as a spin-out from the University of Sheffield, Plasso's innovations addressed critical challenges in biochip performance and reproducibility. The company was acquired by Eurofins Scientific in 2007 to bolster its bioanalytical service capabilities and surface chemistry expertise.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Plasso Technology.